Precision Medicine World Conference (PMWC) Silicon Valley 2018-2018-01-22

Event Information
Event Name: 
Precision Medicine World Conference (PMWC) Silicon Valley 2018
Event Date: 
01/22/2018 - 8:00am
Event Location: 
Computer History Museum, 1401 N Shoreline Blvd, Mountain View
Event Details
Event Type: 
Event Details: 

Precision Medicine World Conference (PMWC) Silicon Valley 2018
Event Date:
January 22-24th, 2018 (8am-5pm)
Event Location:
Computer History Museum, 1401 N Shoreline Blvd, Mountain View, California, 94043

Event Type:
Medical Conference

Event Details:

Precision Medicine World Conference (PMWC) Silicon Valley is organized by Precision Medicine World Conference (PMWC) and will be held during Jan 22 - 24, 2018 at Computer History Museum, Mountain View, California, United States Of America.

The preeminent Precision Medicine World Conference (PMWC) series is recognized as a vital cornerstone for all constituents of the healthcare and biotechnology community and considered an exceptional forum for the exchange of information about the latest advances and topics in technology, clinical implementation, research, and the regulatory and reimbursement sectors. Learn first-hand from the experts in precision medicine: recognized leaders and innovators, top researchers, medical professionals, and more, catalyzing cross-functional fertilization and collaboration.

PMWC 2018 SV, co-hosted by Stanford Health Care, UCSF, Intermountain Healthcare, Duke Health, and Duke University will cover all facets of Precision Medicine including current hot topics like immunotherapy, the Precision Medicine Initiative (All of US), liquid biopsy, the human microbiome, big data, and cancer & companion diagnostics.

Session Themes :

• Metabolomics Proteomics Applications
• Medical Health Apps
• Cancer Immunology, Immunotherapy
• Patient Recruitment for Clinical Trials
• Cancer Stem Cells
• Infectious Disease Monitoring, Pathogen Identification
• The Economics and Financial Impact of Bringing PM to the Clinic
• Addressing Disparities and Public Health
• Reimbursement - the Payer Perspective
• Liquid Biopsies
• Biobanking
• Telemedicine
• Large-scale integrated genomics, phenotype, and clinical data analysis
• Data Sharing
• Interoperability in Healthcare.

Sir John Bell
Regius Professor of Medicine, Oxford University

Dame Sally Davies
Chief Medical Officer, Department of Health, UK Government

Elizabeth Blackburn
Nobel Laureate, President, Salk Institute for Biological Studies

George Sledge
Professor, Division Chief, Stanford University Medical Center

Jeffrey Bluestone
CEO and President, Parker Institute for Cancer Immunotherapy

Christopher Ianelli
Founder and Chief Executive Officer, iSpecimen

Kenneth J. Pienta
Director, Brady Urological Institute, Johns Hopkins Medicine

Roy Beveridge
Senior Vice President & Chief Medical Officer, Humana

Kimberly Blackwell
Professor of Medicine, Assistant Prof. of Radiation Oncology, Duke Cancer Institute

Joshua Denny
Professor of Biomedical Informatics & Medicine, Vanderbilt University Medical Center

Edward S. Kim
Chair, Solid Tumor and Investigational Therapeutics, Levine Cancer Institute

Howard L. McLeod
Medical Director, Personalized Medicine Institute, Moffitt Cancer Center

Lee Newcomer
SVP, UnitedHealthcare Oncology and Genetics

Vinod Khosla
Partner and Founder of Khosla Ventures

Troy Brennan
Executive VP & CMO, CVS Health

Ira Mellman
VP, Cancer Immunology, Genentech

Learn more at: